[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644102":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":10,"responsibleParty":30,"collaborators":10,"id":33,"slug":10,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":34,"sex":40,"minAge":41,"maxAge":42,"enrollmentInfo":43,"targetDuration":10,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":52,"overallStatus":56,"whyStopped":10,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":10},{"fullName":5,"class":6},"Gazi University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Women Undergoing Benign Perianal Surgery",null,"Sexually active female patients aged 18 to 70 years undergoing surgical treatment for benign perianal diseases, including chronic anal fissure, hemorrhoidal disease, and cryptoglandular anal fistula. Participants will be prospectively assessed using FSFI, CCIS\u002FWexner, and VAS scores at baseline and postoperative follow-up.",[13],"Procedure: Surgical Treatment for Benign Perianal Diseases",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Surgical Treatment for Benign Perianal Diseases","Standard surgical treatment for chronic anal fissure, hemorrhoidal disease, or cryptoglandular anal fistula according to routine clinical indications. No experimental intervention will be administered.",[9],[21],{"name":22,"affiliation":23,"role":24},"Mesut Yavaş, MD, Assistant of Professor","Gazi University Faculty of Medicine","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","+905019127287","mesutyavas@gazi.edu.tr",{"type":24,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Mesut YAVAS","Assistant of Professor of Surgery","100644102",false,"NCT07666035","Female Sexual Function After Surgery for Benign Perianal Diseases","Prospective Evaluation of Female Sexual Function Following Surgical Treatment of Benign Perianal Diseases: A Single-Center Observational Cohort Study","PERISEX","Inclusion Criteria:\n\n* Female patients aged 18-70 years\n* Sexually active during the previous 4 weeks\n* Diagnosed with chronic anal fissure, hemorrhoidal disease, or cryptoglandular anal fistula\n* Scheduled for surgical treatment according to routine clinical indications\n* Able to understand and complete study questionnaires\n* Willing to provide written informed consent\n\nExclusion Criteria:\n\n* Inflammatory bowel disease (Crohn's disease or ulcerative colitis)\n* Pregnancy\n* Postpartum period within the previous 12 months\n* Pelvic organ prolapse\n* Previous treatment for female sexual dysfunction\n* Current antidepressant medication use\n* Active psychiatric disorder\n* Gynecological malignancy\n* Previous pelvic radiotherapy\n* Inability or unwillingness to complete study questionnaires\n* Refusal to provide informed consent","FEMALE","18 Years","70 Years",{"count":44,"type":45},120,"ESTIMATED","OBSERVATIONAL","Benign perianal diseases such as chronic anal fissure, hemorrhoidal disease, and cryptoglandular anal fistula may negatively affect female sexual function through pain, bleeding, discharge, discomfort, and impairment in quality of life. Although improvement in male sexual function after surgery for benign anorectal disorders has been reported, data regarding female sexual function remain limited.\n\nThis prospective observational cohort study aims to evaluate changes in Female Sexual Function Index (FSFI) scores following surgical treatment of benign perianal diseases. Female patients undergoing surgery for chronic anal fissure, hemorrhoidal disease, or cryptoglandular anal fistula will be assessed preoperatively and at postoperative 3 and 6 months using the FSFI, Cleveland Clinic Incontinence Score (CCIS\u002FWexner), and Visual Analog Scale (VAS).\n\nThe primary objective is to determine whether female sexual function improves following surgical treatment. Secondary objectives include evaluating the relationship between symptom improvement, continence status, pain reduction, and changes in female sexual function.",[49,50,51],"Chronic Anal Fissure","Hemorrhoidal Disease","Cryptoglandular Anal Fistula",[51,49,50,53,54,55],"FSFI","Sexual Functions","Perianal Pain","NOT_YET_RECRUITING","2026-06-24",{"date":59,"type":60},"2026-06-26","ACTUAL",{"date":62,"type":45},"2026-08",{"date":64,"type":45},"2028-02",{"name":5,"class":6}]